pharma

CONFERENCE

...see all

Biobanking Conference 2010

Analysing the trends and understanding the complexities of biobanking

4th - 5th February 2010, Earls Court Conference Centre, London, UK

Download brochure Products

Background Info
Day 1
Day 2
Partners
Past Papers

Silver Sponsor

Associate Sponsors

Junior Sponsors

Media Partners

Background Info

Key Speakers
• Julie Corfield, R&D Site Biobank Head, Astrazeneca
• Anne Bahr, R&D Data Privacy Coordinator, Sanofi-Aventis
• Dr. Maria Krestyaninova, Biomedical Informatics Coordinator, European Bioinformatics Institute
• Dr. Kristian Unger, Research Associate Division of Investigative Science, Imperial College London
• Kate Rolfvondenbaumen, Regulation Manager, Human Tissue Authority
• Alastair Kent, Director, Genetic Interest Group
• Dr. Alison Parry-Jones, Manager, Wales Cancer Bank
• Marc Martens, Partner, Bird & Bird LLP
• Morag McFarlane, Chief Scientific Officer, Tissue Solutions
• Dr. John Cason, Senior (Non-Clinical) Lecturer in Virology, King’s College London School of Medicine
• Dr. Martin Frey, Senior Product Manager Storage Technologies, Hamilton Bonaduz
• Dr. Stephan Jacobs, Director Sales Network, Chemagen Biopolymer-Technologie
• Jonathan Horan, Product Manager, Vitro
• Dr. Tom Mander, Regional Director of Business Development, Asterand

Biobanking is changing rapidly. Biobanks are playing a vital role in today’s research and development in the fields of drug discovery and bioscience. The biobanking sector has expanded at a tremendous rate in recent years, and has also been facing many legal, financial, ethical, scientific challenges.

Visiongain is happy to announce its inaugural Biobanking Conference which will examine major trends in the biobanking industry and its changing scope. By attending Visiongain’s Biobanking conference delegates will gain an in-depth understanding of the emerging opportunities, challenges and advancements made in the field of biobanking.

Why Attend?

Key benefits
• Assess the increasing need for developing biobanks
• Understand the ethical and regulatory issues
• Implement strategies to develop a cost-effective biobank
• Examine the importance of patient involvement in biobank projects
• Learn about data protection and quality management in biobanking
• Discuss most acute and challenging scientific and policy related matters
• Seize this opportunity to network with leaders from pharma-biotech, healthcare and regulatory agencies

Who should attend?

VPs, Directors, Heads, Managers of:
• Biobank
• Tissue bank
• Biorepository
• Molecular Diagnostics
• Clinical Genetics, Pathology
• Histopathology
• Medical Genomics
• Non-clinical Biosample
• Data Privacy Office
• Health Science Policy
• Scientific and Quality
• Toxicology, Clinical chemistry
• Laboratory and Inventory
• R&D
• Quality Control
• Pharmacogenomics
• Procurement and Strategic Sourcing
• Strategic Outsourcing
• Clinical Research
• Translational Medicine
• Personalized Medicine,
• Bioanalytical Chemistry
• Clinical trials and Non-clinical R & D
• Pharmacogenomics
• Proteomics
• Personalised medicine
• Business development
• Strategic alliances

Others:
• Consultants& Academics
• Regulatory bodies
• Researchers

Venue

Earls Court Conference Centre
Warwick Road
London
SW5 9TA

For accommodation and travel information, see www.eco.co.uk/visitors/

Day 1

Day 1, Thursday 4th February 2010, London, UK

09:30 Registration and refreshments

10:00 Opening address from the chair

Jonathan Horan
Product Manager
Vitro

BIOBANKING - WHERE IS IT HEADING?

10:10 Biobanking to sustain R&D in pharma
• General aspects-purpose and scope
• A-Z perspective of establishing a biobank
• Challenges and needs

Julie Corfield
R&D Site Biobank Head
Astrazeneca

10:50 Utilising retrospective versus prospective samples for research- the hurdles and challenges
• Legal, ethical and consent requirements
• Harmonisation of sample handling/processing and QA systems
• Clinical information/matched samples - requirements vs reality
• Cost and time implications

Morag McFarlane
Chief Scientific Officer
Tissue Solutions

11:30 Morning refreshments

11:50 Biobanks - A Patient and Citizen Perspective
• Broad versus narrow consent
• Feedback of results
• Public and private sector biobanks (and crossover issues between them)
• Disease specific and population biobanks and public engagement
• Collaboration - harmonisation or standardisation?
• Return on investment from a societal perspective

Alastair Kent
Director
Genetic Interest Group

WHAT ARE THE CHALLENGES?

12:30 Biobanking: an attempt at a global regulatory approach
• Typology of biobanks and their respective regulatory framework
• Current legal issues in biobanking (privacy issues, ownership rights, informed consent, etc.)
• Import and export of biobanking materials: a need for harmonisation?

Marc Martens
Partner
Bird & Bird LLP

13:10 Networking lunch

14:30 Challenges for the governance of biobanks
• The mixed message of regulatory bodies: ‘dangers’ and ‘profits’
• The challenge for biobankers: answering the message bottom-up with their governance strategy
• Transparency to the public and patients, avoiding unwarranted expectations
• How to deal with the feed-back issue? (of individual results to participants)
• The traditional view and the good reasons for this view
• Should GWAS change the traditional view of (non) individual feed-back?
• Should GWAS and international cooperation change the traditional view of the promise of privacy?
• The continuous dialogue with stakeholders
• Governance as self-regulation and an investment in trust

Evert-Ben van Veen
Director
Medlawconsult

15:10 Afternoon Refreshments

15:30 Security, Traceability and Interchange: information challenges for biobanks
• Legal and ethical issues in data security
• Maintaining traceability and process integrity throughout the sample life cycle
• Using IT to facilitating sample interchange and harmonise associated information
• Security, Traceability and Interchange: information challenges for biobanks

Jonathan Horan
Product Manager
Vitro

15:50 Legislation & Biobanks- can they co-exist?
• Impact of legislation and HTA regulation on research (including the benefits)
• When is an HTA licence required
• The different requirements for use of tissue from the living and tissue from the deceased
• Non-consensual use of DNALegislation & Biobanks- can they co-exist?

Kate Rolfvondenbaumen
Regulation Manager
Human Tissue Authority

16:30 QA in biobanking and its importance for the generation of experimental data
• QA of issued tissue/ biobanking material has a high impact on the potential of cancer biomarker research
• QA checkpoints in the process of tissue collection and extractions are controlled by using SOPs (standard operation protocols)
• Controlled specimen quality maximises the usability of clinical specimens in terms of the number of potential users and applications and the quality of the resulting data
• The maximum average quality of biobanking material is tissue-specific
• Examples for techniques well applicable on low-quality RNA: MicroRNA and qRT-PCR
• Multiplex PCR – an approach to control the influence of DNA quality on the quality of array copy number data
• Demonstration of the influence of DNA quality on data quality and how bioinformatics deals with the problem

Dr. Kristian Unger
Research Associate Division of Investigative Science
Imperial College London

17:10 Closing remarks from the chair

17:20 Networking drinks
Take your discussions further and build new relationships in a relaxed and informal setting

Day 2

Day 2, Friday 5th February 2010, London, UK

09:30 Registration and refreshments

10:00 Opening address from the chair

Dr. Anne Bahr
R&D Data Privacy Coordinator
Sanofi-Aventis

10:10 Learn about data protection in biobanking
• Personal Data Protection: The main principles
• How can samples from clinical studies be re-used for research?
• Informed consent in practice: Specificities imposed by French, Italian and Spanish authorities
• Standardising practices: What level is possible in a multinational pharmaceutical company?

Anne Bahr
R&D Data Privacy Coordinator
Sanofi Aventis

10:50 SIMBioMS_ - IT solutions for data collection, harmonisation and analysis in large-scale biomedical genomics projects
• Handling and combining sample data (SIMS), assays and measurement data from a wide range of technologies (AIMS), and for browsing, summarizing and annotating its complex data content (SAIL)
• Provides support for multi-partner biomedical data management from the moment of study design to the data analysis
• Sample annotation and tracking, sample size estimation in cross-collection meta-studies, genetic and molecular data consistency, and practical aspects of data standardisation and harmonisation in collaborative discovery projects

Dr. Maria Krestyaninova
Biomedical Informatics Coordinator
European Bioinformatics Institute

11:30 Morning refreshments

RECENT CASE STUDIES

11:50 The infectious diseases biobank at King’s College London: Facilitating translational research of pathogens
• Local need for the resource
• BioBank organisation and operation
• Outcomes
• Future challenges

Dr. John Cason
Senior (Non-Clinical) Lecturer in Virology
King’s College London School of Medicine

12:30 Wales Cancer Bank- Experiences of formulating an access policy and issuing samples to the research community
• What will be made available? Sample availability and processing
• Deciding on an appropriate access policy
• Mechanisms to ensure transparency
• Charging for samples
• Material transfer agreements
• Logistics and training

Dr. Alison Parry-Jones
Manager
Wales Cancer Bank

13:10 Networking lunch

14:30 High performance DNA isolation in european biobanking projects
• Closer insight in european biobanks
• The chemagic separation technology
• Automated DNA isolation from Blood, Saliva, Swabs
• Large sample volumes up to 10 ml
• High throughput applications e.g. > 1.000 samples/d

Dr. Stephan Jacobs
Director Sales Network
Chemagen Biopolymer-Technologie

14:50 From Automated DNA Isolation to Automated Storage - A One-Stop Approach
• How to increase efficiency: Automated DNA isolation
• How to safe your treasure: Automated storage at temperatures down to -80°C
• How to document: Guarantee the complete audit trail form source samples to stored samples

Dr. Martin Frey
Senior Product Manager Storage Technologies
Hamilton Bonaduz

15:10 Afternoon refreshments

FUTURE PERSPECTIVES

15:30 Public attitudes to tissue and organ donation
• Methods of engaging the public on complex and sensitive issues
• Results from several OL research projects relating to tissue and organ donation

Becky Seale
Consultant
Opinion Leader

16:10 Quality management of biobanks
• Database management of a biobank
• Quality assurance of biobanks
• Standardised quality control of human biological samples

Dr. Tom Mander
Regional Director of Business Development
Asterand

16:30 Chair’s closing remarks

16:40 End of Conference

Partners

Silver Sponsor:

NEXUS Biosystems
NEXUS Biosystems is a worldwide developer of enabling technologies and automation systems for life science research. Products include the Universal Store, Universal LabStore, and Universal BioStore family of automated -20C and -80C sample storage and retrieval systems, the Aurora Biotechnologies line of high performance microplates, and the XPeel, a high throughput plate seal removal system. For further information, please visit www.nexusbio.com

chemagen
New Dimensions in Automated Nucleic Acid Isolation
chemagen is a key player in the field of automated nucleic acid isolation. The purification of DNA, mRNA or viral DNA/RNA is facilitated through chemagen's patented M-PVA Magnetic Bead technology. chemagen's high performance instrument is the chemagic Magnetic Separation Module I. It enables automated separation of genomic DNA from 10 µl - 10 ml from fresh or frozen blood. Available kit applications additionally include clinical sample materials such as serum/plasma, tissue, saliva, swabs or faeces. The isolated DNA is subsequently ready to use for many downstream applications or stable for long-term storage. For further information, please visit www.chemagen.com

Asterand plc
Asterand plc is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. Asterand offers unparalleled access to human tissue through its worldwide network of active collaborative donor institutions. Our XpressBANKTM biobank contains several hundred thousand specimens from a broad range of therapeutic areas and with diverse ethnic representation. Asterand's Services division offers exemplary scientific expertise in human tissue research. Through our PhaseZERO® drug discovery services platform, we provide a collaborative scientific approach to deliver human tissue-based data on target & biomarker validation as well as compound potency, efficacy, disposition and safety. For further information, please visit www.asterand.com

Associate Sponsors:

HAMILTON Robotics
For almost 50 years HAMILTON products have successfully served researchers in laboratories all over the world. A long history of successful products began in 1947 with the development of the MICROLAB® syringe by the company's founder
The commitment to precision, accuracy and quality has earned HAMILTON high customer satisfaction. With the MICROLAB® STAR workstation, HAMILTON has again achieved technological leadership. In addition to this open DNA extraction platform, HAMILTON offers modular automated storage solutions with the ASM -20°C system and the SAM -80°C. From sample preparation to storage: One solution from the technology leader. For further information, please visit www.hamiltonrobotics.com

Vitro: Bio-e-Bank
Since 1989, Vitro has pioneered the discovery and development of new reagents, software and techniques - translating them into innovative solutions. This continues with Bio-e-Bank, the complete biobank management system, developed in partnership with Spain's premier DNA and tumour banks.
Bio-e-Bank offers proven data security, sample traceability and process integrity in an intuitive and scalable system. It tracks, annotates and manages samples from reception, through processing to storage. Integrating with your existing HIS and LIMS systems, it helps streamline your processes and helps ensure compliance with the Human Tissue and Data Protection Acts. Visit us at www.bio-e-bank.com

Thermo Fisher Scientific
Thermo Fisher Scientific has the world's largest breadth of offerings for biorepositories from biospecimen collection, processing, testing and storage to sample and data management. The end-to-end portfolio includes the centrifuges, concentrators, freezers, robotics, 2-dimensional barcodes, microplate readers, mass spectrometers and comprehensive services to enable turn-key biobanking solutions. The company will showcase innovative services and software for biorepositories, including laboratory information management systems , laboratory equipment, and storage and related services, marketed under its Thermo Scientific and Fisher BioServices brands at booths. For further information, please visit www.thermo.com/biobanking

Thermo Scientific
Thermo Fisher Scientific offers the largest breadth of biorepository services and software to address the scaling needs of biobanking laboratories worldwide, including market leading Laboratory Information Management Systems (LIMS), analytical equipment, instruments, consumables, reagents, and media. Our biobanking portfolio includes biospecimen preparation, storage, and final testing as well as laboratory cabinets, benches, robotics, microplate readers, mass spectrometers and freezers. We currently manage over 170,000,000 samples worldwide, and also provide kitting, labeling, laboratory, pharmacy, validations, and cold-chain transportation services. We store BSL-3 materials, environmental samples, cell lines, and tissues, as well as blood products, in facilities that are compliant with current good manufacturing laboratory and tissue practices (cGMP, cGLP, cGTP). Visit www.thermo.com/biobanking

Liconic AG
Liconic AG is a major manufacturer and supplier of automated storage systems and environmental chambers for small and large scale sample storage within the laboratory environment. Our market encompasses drug discovery applications within pharmaceutical and biotechnology companies; sample preparation and storage for medical research, clinical trials and pharmaceutical manufacturing applications. For further information, please visit www.liconic.co.uk

Chart
For further information, please visit www.chart-ind.com

Junior Sponsors:

Matrical Bioscience
Matrical Bioscience is a worldwide supplier of automated cell culture systems (MACCS), automated storage platforms (MiniStore), a high throughput sonication device (SonicMan), and a universal microplate washer (SQUIRT). Matrical bioscience also offers consumable microwell plates in 96, 384, and 1536 formats and proprietary MatriTube technology for chemical and biological sample storage. For further information, please visit www.matrical.com

Wheaton Science International
Wheaton Science International offers a variety of containers for biospecimen storage. This offering includes high recovery vials, cryogenic vials and ampules, glass microtubes, and freezer boxes for automated and manual systems. In today's world of biobanking and sample management, sample integrity means everything. With the new Wheaton CryoELITE® Cryogenic Vial, sample tracking is simple and permanent with the unique 2D Matrix bar code bottom insert. For further information, please visit www.wheatonsci.com

Media Partners:

PharmiWeb.com
PharmiWeb.com is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email: corporate@pharmiweb.com

BIOTECHNOLOGY EUROPE
BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the main goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com

Future Pharmaceuticals
Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries' top issues and the solutions top-tier vendors can provide. For further information, please visit www.futurepharmaus.com

InPharm
InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafile and Pharmafocus. For further information please visit: www.In-Pharm.com

Pharma Connections Worldwide
Pharma Connections Worldwide® is the leading professional business networking website focused in the Pharmaceutical, Biotechnology and Life Sciences research industry. Our goal is to provide a conduit for delivery of premiere content coupled with the right clientele in order to facilitate business development opportunities among industry professionals responsible for making key decisions in a global marketplace. For further information please visit www.pharmaconnections.com

Trinean
Trinean develops and produces a new approach for high throughput UV-VIS spectral analysis of microliter droplets of DNA/RNA, protein or small compounds. The first product is the DropSense96^®, a multi-channel spectrophotometer, in combination with disposable microfluidic chips. These DropPlate16/96^® chips have 16 to 96 sample reservoirs to avoid any sample evaporation and are suited for quick & precise absorption measurements of small (1,5-2,5 l) samples with a broad concentration range (5-3800 ng/µl dsDNA). Furthermore the DropQuant user interface software is designed to be flexible, easy to use and compatible with Microsoft excel or/and an external databases (LIMS). For further information, please visit www.trinean.com

Enquiries

If you would like more information on the range of sponsorship or exhibition possibilities for visiongain's Biobanking Conference 2010, please contact:
Christopher Clegg, +44 (0)20 7549 9943
christopher.clegg@visiongainglobal.com
Ronald Magali, +44 (0)20 7549 9934
ronald.magali@visiongainglobal.com

Past Papers

Speaker presentations are free to delegates. If you are unable to attend the event, the presentations are published two weeks after the event and are available to purchase.

Buy Now